Cancer BiologybioRxivPreprint
Nischarin agonist rilmenidine shows antimetastatic potential in pancreatic ductal adenocarcinoma
Kristina Živić, Marijana Pavlović, Marija Ostojić…·Jelena Grahovac
This study investigates the antimetastatic potential of Nischarin agonist rilmenidine in pancreatic ductal adenocarcinoma using in vitro and in vivo models.